Campbell & Co. Investment Adviser »

Immunome shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Immunome (IMNM) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Immunome

Tip: Access up to 7 years of quarterly data

All positions including Immunome held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunome by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2026-03-31 $394k 18k 21.87

More positions owned by Campbell & Co. Investment Adviser

Bank of Nova Scotia/The Common Stock (BNS)
Shell Adr (SHEL)
Illinois Tool Works Common Stock (ITW)
Williams Cos Inc/The Common Stock (WMB)
Alphabet Common Stock (GOOGL)
Phillips 66 Common Stock (PSX)
Murphy Oil Corp Common Stock (MUR)
Teledyne Technologies Common Stock (TDY)
Nordson Corp Common Stock (NDSN)
Agilent Technologies Common Stock (A)
EQT Corp Common Stock (EQT)
Expand Energy Corp Common Stock (EXE)
Atmos Energy Corp Common Stock (ATO)
Chevron Corp Common Stock (CVX)
Baker Hughes Common Stock (BKR)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Immunome

FMR
T. Rowe Price Investment Management
BlackRock
Vanguard Group
Redmile Group
State Street Corporation
PRIMECAP Management Company
Wellington Management Company
Vanguard Capital Management
Driehaus Capital Management
Enavate Sciences GP
Morgan Stanley
Geode Capital Management
Leucadia National Corporation
Sofinnova Ventures

View all funds holding Immunome